Gastrointestinal (GIT) Manifestation and Esophagogastroduodenoscopy (EGD) Findings in Systemic Lupus Erythematous (SLE) Patients
Al Amir, H., Abady, W., Amin, M. (2025). Gastrointestinal (GIT) Manifestation and Esophagogastroduodenoscopy (EGD) Findings in Systemic Lupus Erythematous (SLE) Patients. EKB Journal Management System, 29(1), 117-124. doi: 10.21608/smj.2025.345758.1518
Haitham Mohammad Al Amir; Wael Abdel Mohsen Abady; Mohammed Ezzat Amin. "Gastrointestinal (GIT) Manifestation and Esophagogastroduodenoscopy (EGD) Findings in Systemic Lupus Erythematous (SLE) Patients". EKB Journal Management System, 29, 1, 2025, 117-124. doi: 10.21608/smj.2025.345758.1518
Al Amir, H., Abady, W., Amin, M. (2025). 'Gastrointestinal (GIT) Manifestation and Esophagogastroduodenoscopy (EGD) Findings in Systemic Lupus Erythematous (SLE) Patients', EKB Journal Management System, 29(1), pp. 117-124. doi: 10.21608/smj.2025.345758.1518
Al Amir, H., Abady, W., Amin, M. Gastrointestinal (GIT) Manifestation and Esophagogastroduodenoscopy (EGD) Findings in Systemic Lupus Erythematous (SLE) Patients. EKB Journal Management System, 2025; 29(1): 117-124. doi: 10.21608/smj.2025.345758.1518

Gastrointestinal (GIT) Manifestation and Esophagogastroduodenoscopy (EGD) Findings in Systemic Lupus Erythematous (SLE) Patients

Sohag Medical Journal
Volume 29, Issue 1, 2025, Pages 117-124    PDF (824.63 K)
Document Type: Original Article
DOI: 10.21608/smj.2025.345758.1518
Authors
Haitham Mohammad Al Amir* 1; Wael Abdel Mohsen Abady2; Mohammed Ezzat Amin3
1Internal Medicine department, Faculty of Medicine, Sohag University
2Physical medicine, Rheumatology and rehabilitation department, Faculty of Medicine, Southvally university
3Department of Internal Medicine, faculty of medicine, Sohag University.
Abstract
Background: Systemic lupus erythematosus (SLE), an autoimmune illness, with severe inflammatory signs. Skin, neurological, central nervous system, and hematological involvement are common. Objectives: This study aimed to assess gastrointestinal (GIT) proof and superior endoscopic outcomes in SLE cases. Methods: According to the 1997 American College of Rheumatology (ACR) revised categorization tests, 40 SLE cases, aged 18 and older, of either gender, and accompanied by two people of the same gender, participated in a cross-localized ER study. Laboratory investigations, including thorough ancestry pictures, liver and kidney function tests, lipid sketches, cells with hemoglobin sedimentation rate, C-reactive protein, complements, antagonistic-dsDNA, and a full excretion study, were performed on all patients. Comprehensive abdominal ultrasonography was performed on all cases, and esophagogastroduodenoscopy (EGD) was performed on selected prisoners. Result: Regarding the dispassionate symptoms of GIT proofs, 8 (42.11%) inmates believed that things would go badly, 7 (36.84%) were gaunt, 6 (31.58%) inmates experienced abdominal pain, 3 (15.79%) experienced bloating, 3 (15.79%) experienced loose bowels, 3 (15.79%) experienced nausea or disgorging, 3 (15.79%) experienced burden loss, and 1 (5.26%) experienced constipation. Conclusions: The doctors see the GI symptoms of SLE since early detection and the right circumstances can affect the patients' prognosis. In our investigation, EGD demonstrated saddening symptoms that are indicative of SLE.
Keywords
Gastrointestinal; patients with systemic lupus erythematous; esophagogastroduodenoscopy
Supplementary Files
Statistics
Article View: 154
PDF Download: 72